NEW YORK, Feb. 12, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers.  Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies. 

Kuehn Law, PLLC (PRNewsfoto/Kuehn Law, PLLC)

Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process: 

  • Ambrx Biopharma, Inc. (Nasdaq: AMAM) click to participate

Ambrx Biopharma has agreed to be acquired by Johnson & Johnson. Under the agreement, shareholders of Ambrx will be entitled to a payment of $28.00 per share in cash.

  • Masonite International Corporation (NYSE: DOOR) click to participate

Masonite has agreed to be acquired by Owens Corning. Under the agreement, shareholders of Masonite will be entitled to a payment of $133.00 per share in cash.

  • CymaBay Therapeutics, Inc. (Nasdaq: CBAY) click to participate

CymaBay Therapeutics has agreed to be acquired by Gilead Sciences. Under the agreement, shareholders of CymaBay Therapeutics will be entitled to a payment of $32.50 per share in cash.

  • ContextLogic Inc. (Nasdaq: WISH) click to participate

ContextLogic has agreed to be acquired by Qoo10. Under the agreement, shareholders of ContextLogic will be entitled to a payment of $6.50 per share in cash.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

How to Get Involved:

Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients.  Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-amam-door-cbay-and-wish-investors-to-contact-law-firm-302059770.html

SOURCE Kuehn Law, PLLC

Copyright 2024 PR Newswire

Cymabay Therapeutics (NASDAQ:CBAY)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse Cymabay Therapeutics
Cymabay Therapeutics (NASDAQ:CBAY)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse Cymabay Therapeutics